PMK ethyl glycidate | Cas# 28578-16-7

Initial Step: Enter the in vivo formulation (This is only a calculator, not a formulation. Please contact us first if there is no in vivo formulation at the solubility section.)

Looking for more details on synthesis cas 28578-16-7? Do not hesitate to reach out to us.

Preliminary Step: Enter the information below (It is recommended to include an additional animal to account for potential loss during the experiment)

Calculation results:

Working concentration: mg/ml;

Preparation of DMSO master liquid: mg of drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL, please contact us first if the concentration surpasses the DMSO solubility of the drug batch. )

In vivo formulation preparation: Combine μL of DMSO master liquid, then introduce μL of PEG300, mix until clear, follow with μL of Tween 80, mix and clarify, finally add μL of ddH2O, mix until clear.

In vivo formulation preparation: Combine μL of DMSO master liquid, then add μL of Corn oil, mix until clear.

Note: 1. Ensure the liquid is clear before adding the next solvent.
2. Add the solvents in order. The solution obtained from the previous addition must be clear before proceeding to the next solvent. Physical methods like vortex, ultrasound, or a hot water bath can aid in dissolving.
3. All co-solvents mentioned above are available for purchase on the GlpBio website.

Contact us to discuss your requirements for 1451-82-7 quotes. Our experienced sales team can assist you in identifying the best options for your needs.

Click here to request a quote and get 15% off on Cayman's products.

Cayman Chemical's mission is to support research globally by providing the essential tools necessary for advancements in human and animal health. Our priority is offering the highest quality products at an accessible price point.

Our team of scientists excels in the synthesis, purification, and characterization of various biochemicals, ranging from small drug-like heterocycles to complex biolipids and fatty acids. We are also adept in assay and antibody development, protein expression, crystallization, and structure determination.

With over three decades of expertise in lipid biochemistry, Cayman has contributed significantly to research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This expertise has resulted in the production of high-quality reagents for cancer research, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and more.

Our organic and analytical chemists are dedicated to the swift development of manufacturing processes and analytical methods for clinical and commercial GMP-API production. We are also engaged in pre-clinical drug discovery in areas such as bone restoration, muscular dystrophy, oncology, and inflammation. A separate team of Ph.D. scientists focuses on Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our chemists are proficient in performing comprehensive sample analysis for various assays. We provide a wide array of analytical services using LC-MS/MS, HPLC, GC, and other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, offering high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and academic research institutions for forensic analysis. We are accredited by ACLASS Accreditation Services with dual certification to ISO/IEC 17025:2005 and ISO Guide 34:2009.

For more information on bromazolam cas 71368-80-4 manufacturer. Please contact us for professional assistance.